Natera- Signatera - Exhibitor



Company Website

Contact Information:

Jennifer Broussard
jbroussard@natera.com
9044000210

Virtual Exhibit Hall Home

 

Singatera is a personalized, tumor-informed assay for ultra sensitive detection of molecular residual disease (MRD). Signatera can be used in all solid tumor types.
Signatera answers the questions:

  • Is there residual disease?
  • Is the treatment working?
  • Is the tumor truly progressing?
  • Is there a need to change or reinitiate the treatment?